- Home
- UNCY vs IDN Comparison
UNCY vs IDN Comparison
Compare UNCY & IDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UNCY | IDN |
|---|---|---|
| Founded | 2016 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 121.9M | 101.6M |
| IPO Year | 2021 | 1999 |
Fundamental Metrics
Financial Performance| Metric | UNCY | IDN |
|---|---|---|
| Price | $6.23 | $6.68 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $44.50 | $6.50 |
| AVG Volume (30 Days) | 384.0K | ★ 934.3K |
| Earning Date | 11-12-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.01 |
| Revenue | N/A | ★ $21,968,000.00 |
| Revenue This Year | N/A | $12.25 |
| Revenue Next Year | N/A | $11.20 |
| P/E Ratio | ★ N/A | $691.07 |
| Revenue Growth | N/A | ★ 14.20 |
| 52 Week Low | $3.71 | $2.17 |
| 52 Week High | $11.00 | $7.48 |
Technical Indicators
Market Signals| Indicator | UNCY | IDN |
|---|---|---|
| Relative Strength Index (RSI) | 57.10 | 61.90 |
| Support Level | $6.31 | $6.14 |
| Resistance Level | $6.95 | $6.69 |
| Average True Range (ATR) | 0.42 | 0.35 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 53.72 | 81.32 |
Price Performance
Historical ComparisonAbout UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.
About IDN Intellicheck Inc.
Intellicheck Inc is a trusted industry leader in technology solutions that stop identity theft and fraud with real-time identification authentication and age verification. The group delivers on-demand digital and physical identity verification solutions for KYC, AML, fraud prevention, and age verification needs. The products of the company include solutions for preventing identity fraud across any industry delivered via smartphone, tablet, POS integration or other electronic devices.